Delisting risk
ERNA · NASDAQ · Biotechnology

Ernexa Therapeutics (ERNA)

Develops off-the-shelf engineered iMSC therapies for cancer and autoimmune disease.

$4.54
Pre-market+0.04 (+1.00%)
At close$4.50(+3.33%)

Breakdown13F · 13D/G · Form 4

Institutions19 holders · as of Mar 31, 20268.76%143.0K shares
Insiders3 holders · as of Aug 27, 202617.10%279.2K shares
Otherremainder74.14%1.21M shares

1.63M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (1.63M in the company's Sep 3, 2026 report, 314.1K elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Charles CheringtonInsider10 percent owner
16.61%271,178Form 4filed Feb 17, 2026
Bleichroeder LPInstitution
4.90%2.00M13Fas of Mar 31, 2026
Dauntless Investment Group, LLCInstitution
1.50%612,44313Fas of Mar 31, 2026
Ci Private Wealth, LLCInstitution
1.07%438,09313Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.60%244,44613Fas of Mar 31, 2026
David PolinskyInsiderdirector
0.49%8,000Form 4filed Aug 27, 2026
XTX Topco LtdInstitution
0.13%54,33813Fas of Mar 31, 2026
Warberg Asset Management LLCInstitution
0.12%50,00013Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
0.10%41,16713Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
0.08%33,07613Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
0.06%26,50413Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.06%25,44713Fas of Mar 31, 2026
UBS Group AGInstitution
0.05%21,23313Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution
0.04%16,63113Fas of Mar 31, 2026
Sippican Capital AdvisorsInstitution
0.02%10,00013Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.00%82013Fas of Mar 31, 2026
Assetmark, IncInstitution
0.00%13313Fas of Mar 31, 2026
Sandra M. GurrolaInsiderofficer: Sr. VP of Finance
0.00%4Form 4filed Jul 7, 2025
BNP Paribas Arbitrage, SNCInstitution
0.00%1013Fas of Mar 31, 2026
Montag A & Associates IncInstitution
0.00%813Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution
0.00%613Fas of Mar 31, 2026
Activest Wealth ManagementInstitution
0.00%313Fas of Mar 31, 2026
Iaf, LLCStrategic
5.20% of class, as filed13Gfiled May 14, 2025
Investments LLCStrategic
19.99% of class, as filed13G/Afiled Jul 21, 2023
Purchase Capital LLCStrategic
5.00% of class, as filed13Gfiled Aug 28, 2023

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

19 holders · 3.57M shares · 10 new positions · 13 increased · 0 reduced · 5 closed

HolderShares% outstandingChg q/qFiled
Bleichroeder LP2.00M122.52%+2.00MnewMay 14, 2026
Dauntless Investment Group, LLC612.4K37.52%+612.4KnewMay 14, 2026
Ci Private Wealth, LLC438.1K26.84%+1May 15, 2026
Geode Capital Management, LLC244.4K14.97%+220.8KMay 15, 2026
XTX Topco Ltd54.3K3.33%+54.3KnewMay 15, 2026
Warberg Asset Management LLC50.0K3.06%+50.0KnewMay 7, 2026
Jane Street Group, LLC41.2K2.52%+41.2KnewMay 12, 2026
Citadel Advisors LLC33.1K2.03%+33.1KnewMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Charles Cherington37.90%13DJun 11, 2025
Freebird Partners LP9.90%120.4K13GMay 15, 2026
Shameek Konar9.70%118.3K13GMay 13, 2026
John D. Halpern9.60%13GMay 15, 2025
Bleichroeder LP6.86%80.0K13GMay 14, 2026
Iaf, LLC5.20%13GMay 14, 2025

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Feb 10, 2026
Charles Cherington10 percent owner
Purchase · 2 lots8,000,000$0.590010,779,440

CongressHouse and Senate disclosures

Not reported.